Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNE1 | P15382 | 1/20 | 0.36 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15820172 | 0.86 | ATM (0.40) | KCNE1KCNQ1LMNACYP2C9GAA | |
| SCHEMBL3301289 | 0.83 | KCNE1 (0.34) | KCNE1KCNQ1LMNACYP2C9GAA | |
| SCHEMBL5463297 | 0.80 | LMNA (0.37) | KCNE1KCNQ1LMNACYP2C9SMN1; SMN2 | |
| SCHEMBL1963793 | 0.76 | KCNE1 (0.36) | KCNE1KCNQ1LMNAATMKMT2A | |
| SCHEMBL3894061 | 0.75 | KCNE1 (0.35) | KCNE1KCNQ1LMNASMN1; SMN2GAA | |
| SCHEMBL8800080 | 0.75 | KCNE1 (0.37) | KCNE1KCNQ1LMNACYP2C9ATM | |
| SCHEMBL29249349 | 0.74 | CHRNB2 (0.36) | KCNE1KCNQ1LMNASMN1; SMN2KMT2A | |
| Arsenic SCHEMBL8675880 | 0.74 | LMNA (0.34) | KCNE1KCNQ1LMNASMN1; SMN2KMT2A | |
| SCHEMBL4383887 | 0.73 | KMT2A (0.39) | KCNE1KCNQ1LMNACYP2C9SMN1; SMN2 | |
| SCHEMBL27887531 | 0.72 | ATM (0.42) | KCNE1KCNQ1LMNACYP2C9GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004045556-A2 | METHODS FOR INHIBITING ALLERGIC INFLAMMATION AND OTHER RESPONSES INITIATED BY POLLENS, MOLDS, AND OTHER NON-ANIMAL DERIVED ALLERGENS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2004-06-03 | — | — | WO | claimed |
| EP-4655415-A1 | COMPOSITIONS AND METHODS FOR SIGNAL-AMPLIFIED FLAP CLEAVAGE ASSAYS | Exact Sciences Corporation (US) | 2025-12-03 | — | — | EP | disclosed |
| EP-4514996-A1 | LOW-BIAS SEQUENTIAL MULTIPLEX AMPLIFICATION ASSAYS | Exact Sciences Corporation (US) | 2025-03-05 | — | — | EP | disclosed |
| US-20240424010-A1 | NICOTINAMIDE RIBOSIDE TRIOLEATES CHLORIDE, COMPOSITIONS CONTAINING THIS COMPOUND, AND METHODS OF MAKING AND USING THIS COMPOUND | NESTLE SA (CH) | 2024-12-26 | — | — | US | disclosed |
| CN-119082301-A | Cancer screening methods, kits, compositions and systems | 梅约医学教育与研究基金会 | 2024-12-06 | — | — | CN | disclosed |
| CN-118910258-A | Cancer screening methods, kits, compositions and systems | 梅约医学教育与研究基金会 | 2024-11-08 | — | — | CN | disclosed |
| CN-113811622-B | Detection of pancreatic ductal adenocarcinoma in plasma | 梅约医学教育与研究基金会 | 2024-09-17 | — | — | CN | disclosed |
| CN-113557308-B | Detection of endometrial cancer | 梅约医学教育与研究基金会 | 2024-08-16 | — | — | CN | disclosed |
| EP-4408192-A1 | NICOTINAMIDE RIBOSIDE TRIOLEATES CHLORIDE, COMPOSITIONS CONTAINING THIS COMPOUND, AND METHODS OF MAKING AND USING THIS COMPOUND | Société des Produits Nestlé S.A. (CH) | 2024-08-07 | — | — | EP | disclosed |
| WO-2024159163-A1 | COMPOSITIONS AND METHODS FOR SIGNAL-AMPLIFIED FLAP CLEAVAGE ASSAYS | EXACT SCIENCES CORPORATION (US) | 2024-08-02 | — | — | WO | disclosed |
| US-7109329-B2 | Neurologically active compounds and compounds with multiple activities | NAFTCHI N ERIC | 2006-09-19 | — | — | US | disclosed |
| EP-1670949-A2 | IMPROVED BISULFITE CONVERSION OF DNA | Epigenomics AG (DE) | 2006-06-21 | — | — | EP | disclosed |
| WO-2006039563-A2 | METHOD FOR PROVIDING DNA FRAGMENTS DERIVED FROM AN ARCHIVED SAMPLE | EPIGENOMICS AG (DE) | 2006-04-13 | — | — | WO | disclosed |
| EP-1591099-A2 | Methods for stabilizing ingredients within cosmetics, personal care and household products | MERCK PATENT GmbH (DE) | 2005-11-02 | — | — | EP | disclosed |
| WO-2005038051-A2 | IMPROVED BISULFITE CONVERSION OF DNA | EPIGENOMICS AG (DE) | 2005-04-28 | — | — | WO | disclosed |
| US-6413962-B1 | ANESTHESIA AND TEMPERATURES REDUCTION; ALPHA-ADRENOCEPTOR AGONIST; RESTORATIVE TO CENTRAL NERVOUS SYSTEM, ESPECIALLY MOTOR AND SENSORY FUNCTIONAL LOSSES FROM TRAMATIC SPINAL CORD INJURIES; ANTISPASTICS; NONSEDATIVE; SIDE EFFECT REDUCTION | NAFTCHI N ERIC (US) | 2002-07-02 | — | — | US | disclosed |
| WO-2002030412-A1 | COMPOSITIONS CONTAINING TRYPTAMINES, CAROTENOIDS AND TOCOTRIENOLS HAVING SYNERGISTIC ANTIOXIDANT | ASHNI NATURACEUTICALS, INC. (US) | 2002-04-18 | — | — | WO | disclosed |
| US-6369261-B1 | CYCLOPROPYLBENZENE DERIVATIVE OF ACIDS OR ESTERS | ALLERGAN SALES, INC. | 2002-04-09 | — | — | US | disclosed |
| US-6069169-A | OXA acids and related compounds for treating skin conditions | AVON PRODUCTS, INC. (US) | 2000-05-30 | — | — | US | disclosed |
| WO-1997046231-A1 | OXA ACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS | AVON PRODUCTS, INC. (US) | 1997-12-11 | — | — | WO | disclosed |